3 Promising Penny Stocks With Under $200M Market Cap

The market has stayed flat over the past week, but over the last year, it has risen by 18%, with earnings forecasted to grow annually by 17%. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer substantial opportunities when built on solid financials. This article highlights several penny stocks that combine balance sheet strength with potential for outsized gains, offering investors a chance to discover hidden value in quality companies.

Underneath we present a selection of stocks filtered out by our screen.

Gamehaus Holdings (GMHS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Gamehaus Holdings Inc. is a technology-driven mobile game publishing company that distributes games from its developer partners across global markets, with a market cap of $41.45 million.

Operations: Gamehaus Holdings generates revenue from its Computer Graphics segment, totaling $110.90 million.

Market Cap: $41.45M

Gamehaus Holdings, with a market cap of US$41.45 million, has shown stable earnings growth at 5.5% annually over five years, though recent growth slowed to 1.6%. Despite its high-quality earnings and a favorable price-to-earnings ratio of 9.6x compared to the US market average, its return on equity is low at 12.7%. The company is debt-free and has robust short-term assets exceeding liabilities significantly. Recent activities include completing a share buyback plan and filing a $200 million shelf registration for securities issuance, indicating strategic financial maneuvers despite management's limited experience with an average tenure of 1.6 years.

• Click here to discover the nuances of Gamehaus Holdings with our detailed analytical financial health report.
• Gain insights into Gamehaus Holdings' historical outcomes by reviewing our past performance report.

Waldencast (WALD)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Waldencast plc is a company engaged in the beauty and wellness industry across various regions including the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand with a market cap of approximately $171.87 million.

Operations: The company's revenue is derived from its Obagi segment, which generated $161.63 million, and its Milk Makeup segment, contributing $110.44 million.

Market Cap: $171.87M

Waldencast plc, with a market cap of US$171.87 million, operates in the beauty and wellness sector but remains unprofitable. Its Obagi segment generated US$161.63 million, while Milk Makeup contributed US$110.44 million in revenue. Despite high volatility and a negative return on equity of -49.6%, the company maintains a satisfactory net debt to equity ratio of 21.2% and sufficient cash runway for over three years due to positive free cash flow growth at 25.9% annually. Recent FDA approval for Obagi saypha ChIQ expands its U.S market presence, potentially enhancing future revenue streams amidst executive changes.

• Click here and access our complete financial health analysis report to understand the dynamics of Waldencast.
• Evaluate Waldencast's prospects by accessing our earnings growth report.

NameSilo Technologies (URLO.F)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: NameSilo Technologies Corp. operates through its subsidiaries to offer domain name registration services across the United States, East and South Asia, South East Asia, Australasia, and internationally with a market cap of $82.40 million.

Operations: There are no specific revenue segments reported for NameSilo Technologies Corp.

Market Cap: $82.4M

NameSilo Technologies Corp., with a market cap of US$82.40 million, has shown revenue growth, reporting CA$35.79 million in sales for the first half of 2026 compared to CA$31.99 million the previous year. Despite this, its net income decreased to CA$1.63 million from CA$1.99 million over the same period, indicating challenges in maintaining profitability margins amidst growing sales figures. The company’s debt is well-covered by operating cash flow and interest payments are significantly covered by EBIT, suggesting financial stability despite not covering short-term liabilities with short-term assets. Its subsidiary Marlow AI Inc.'s recent beta launch could diversify revenue streams and enhance technological offerings.

• Unlock comprehensive insights into our analysis of NameSilo Technologies stock in this financial health report.
• Explore historical data to track NameSilo Technologies' performance over time in our past results report.

Turning Ideas Into Actions

• Click through to start exploring the rest of the 310 US Penny Stocks now.
• Ready For A Different Approach? AI is about to change healthcare. These 130 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com